150 related articles for article (PubMed ID: 6243)
1. Clinical pharmacokinetics of beta-adrenoreceptors blockers.
Johnsson G; Regårdh CG
Drugs; 1976; 11 SUPPL 1():111-21. PubMed ID: 6243
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
4. Correlation between pharmacological response, kinetics of plasma concentration and in vitro receptor affinities exemplified with beta-adrenoceptor blocking drugs.
Wellstein A; Palm D
Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):641-4. PubMed ID: 6151037
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.
Wellstein A; Palm D; Belz GG; Pitschner HF
Arzneimittelforschung; 1985; 35(1):2-6. PubMed ID: 2859024
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
Borchard U
Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers and renal function.
Wilkinson R
Drugs; 1982 Mar; 23(3):195-206. PubMed ID: 6122552
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.
Frishman WH; Alwarshetty M
Clin Pharmacokinet; 2002; 41(7):505-16. PubMed ID: 12083978
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.
Riddell JG; Harron DW; Shanks RG
Clin Pharmacokinet; 1987 May; 12(5):305-20. PubMed ID: 2886244
[TBL] [Abstract][Full Text] [Related]
10. Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.
Park BK
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):3S-10S. PubMed ID: 6146338
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of ketanserin.
Persson B; Heykants J; Hedner T
Clin Pharmacokinet; 1991 Apr; 20(4):263-79. PubMed ID: 2036747
[TBL] [Abstract][Full Text] [Related]
12. Drug-drug interactions of beta-adrenoceptor blockers.
Brodde OE; Kroemer HK
Arzneimittelforschung; 2003; 53(12):814-22. PubMed ID: 14732961
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol.
Grevel J
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S16-9. PubMed ID: 2439812
[TBL] [Abstract][Full Text] [Related]
14. [Human pharmacokinetics of molsidomine].
Singlas E; Martre H
Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):503-9. PubMed ID: 6364946
[TBL] [Abstract][Full Text] [Related]
15. Enzyme induction and beta-adrenergic receptor blocking drugs.
Branch RA; Herman RJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):77S-84S. PubMed ID: 6146342
[TBL] [Abstract][Full Text] [Related]
16. The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.
Lennard MS; Tucker GT; Woods HF
Clin Pharmacokinet; 1986; 11(1):1-17. PubMed ID: 2868819
[TBL] [Abstract][Full Text] [Related]
17. Relationship between pharmacokinetics and pharmacodynamics of the beta adrenergic blocking drug sotalol in dogs.
Ishizaki T; Tawara K
J Pharmacol Exp Ther; 1979 Nov; 211(2):331-7. PubMed ID: 501565
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Nattel S; Gagne G; Pineau M
Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of prazosin.
Jaillon P
Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
[TBL] [Abstract][Full Text] [Related]
20. Influence of smoking and age on pharmacokinetics of beta-receptor blockers.
Hitzenberger G; Fitscha P; Beveridge T; Nüesch E; Pacha W
Gerontology; 1982; 28 Suppl 1():93-100. PubMed ID: 6123470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
